Loss-of-function mutations in SGCE, which encodes ε-sarcoglycan (ε-SG), cause myoclonus-dystonia syndrome (OMIM159900, DYT11). A “major” ε-SG protein derived from CCDS5637.1 (NM_003919.2) and a “brain-specific” protein, that includes sequence derived from alternative exon 11b (CCDS47642.1, NM_001099400.1), are reportedly localized in post- and pre-synaptic membrane fractions, respectively. Moreover, deficiency of the “brain-specific” isoform and other isoforms derived from exon 11b may be central to the pathogenesis of DYT11. However, no animal model supports this hypothesis. Gene-trapped ES cells (CMHD-GT_148G1-3, intron 9 of NM_011360) were used to generate a novel Sgce mouse model (C57BL/6J background) with markedly reduced expression of...
Myoclonus-dystonia (M-D; OMIM 159900) is an autosomal dominant movement disorder characterized by al...
Myoclonus-dystonia (DYT-SGCE, formerly DYT11) is characterized by alcohol-sensitive, myoclonic-like ...
Mutations of e-sarcoglycan gene (SGCE) have been implicated in myoclonus-dystonia (M-D), a movement ...
Loss-of-function mutations in SGCE, which encodes ε-sarcoglycan (ε-SG), cause myoclonus-dystonia syn...
Myoclonus Dystonia (MD) is an autosomal dominant movement disorder characterized by bilateral myoclo...
AbstractMutations of SGCE encoding ε-sarcoglycan cause myoclonus-dystonia. SGCE is paternally expres...
The dystonias are a common clinically and genetically heterogeneous group of movement disorders. Mor...
Myoclonus-dystonia syndrome (MDS) is a genetically heterogeneous disorder characterized by myoclonic...
Myoclonus Dystonia (MD) is an autosomal dominant disease with high but incomplete penetrance and is ...
BACKGROUND: Myoclonus dystonia syndrome (MDS) is a hyperkinetic movement disorder caused, in a propo...
Myoclonus dystonia (DYT11, OMIM 159900) (MD) is a movement disorder characterized by bilateral alcoh...
Missense mutations in the SGCE gene encoding ε-sarcoglycan account for approximately 15% of SGCE-pos...
Mutations in the gene for epsilon sarcoglycan (ε-SG) are associated with a disorder of the central n...
Myoclonus dystonia (MD) is a neurogenic movement disorder that can be caused by mutations in the SGC...
BACKGROUND: Myoclonus-dystonia is a neurogenic movement disorder caused by mutations in the gene enc...
Myoclonus-dystonia (M-D; OMIM 159900) is an autosomal dominant movement disorder characterized by al...
Myoclonus-dystonia (DYT-SGCE, formerly DYT11) is characterized by alcohol-sensitive, myoclonic-like ...
Mutations of e-sarcoglycan gene (SGCE) have been implicated in myoclonus-dystonia (M-D), a movement ...
Loss-of-function mutations in SGCE, which encodes ε-sarcoglycan (ε-SG), cause myoclonus-dystonia syn...
Myoclonus Dystonia (MD) is an autosomal dominant movement disorder characterized by bilateral myoclo...
AbstractMutations of SGCE encoding ε-sarcoglycan cause myoclonus-dystonia. SGCE is paternally expres...
The dystonias are a common clinically and genetically heterogeneous group of movement disorders. Mor...
Myoclonus-dystonia syndrome (MDS) is a genetically heterogeneous disorder characterized by myoclonic...
Myoclonus Dystonia (MD) is an autosomal dominant disease with high but incomplete penetrance and is ...
BACKGROUND: Myoclonus dystonia syndrome (MDS) is a hyperkinetic movement disorder caused, in a propo...
Myoclonus dystonia (DYT11, OMIM 159900) (MD) is a movement disorder characterized by bilateral alcoh...
Missense mutations in the SGCE gene encoding ε-sarcoglycan account for approximately 15% of SGCE-pos...
Mutations in the gene for epsilon sarcoglycan (ε-SG) are associated with a disorder of the central n...
Myoclonus dystonia (MD) is a neurogenic movement disorder that can be caused by mutations in the SGC...
BACKGROUND: Myoclonus-dystonia is a neurogenic movement disorder caused by mutations in the gene enc...
Myoclonus-dystonia (M-D; OMIM 159900) is an autosomal dominant movement disorder characterized by al...
Myoclonus-dystonia (DYT-SGCE, formerly DYT11) is characterized by alcohol-sensitive, myoclonic-like ...
Mutations of e-sarcoglycan gene (SGCE) have been implicated in myoclonus-dystonia (M-D), a movement ...